Chinese drug developer Biokin postpones Hong Kong listing
- Posted on November 12, 2025
- By South China Morning Post
- 1 Views
Chinese drug developer Biokin postpones Hong Kong listing
Decision likely reflects ‘some pullback in risk appetite, with growth-stock share prices coming off their highs’, Morningstar analyst says.
